We are live on ! Find out more
BAM

Broadcrest Asset Management Portfolio holdings

AUM $44.1M
1-Year Est. Return 4.51%
This Fund
S&P 500
This Quarter Est. Return
+5.86%
1 Year Est. Return
-4.51%
3 Year Est. Return
+54.14%
5 Year Est. Return
10 Year Est. Return
AUM
$91.6M
AUM Growth
+$4.02M
Cap. Flow
+$1.24M
Cap. Flow %
1.35%
Top 10 Hldgs %
100%
Holding
8
New
1
Increased
4
Reduced
Closed
1

Top Buys

Rank Stock Value
1
TECH icon
Bio-Techne
TECH
+$7.94M
2
TRNS icon
Transcat
TRNS
+$3.05M
3
ENOV icon
Enovis
ENOV
+$2.58M
4
TYL icon
Tyler Technologies
TYL
+$1.63M
5
NOMD icon
Nomad Foods
NOMD
+$1.58M

Top Sells

Rank Stock Value
1
VRT icon
Vertiv
VRT
+$15.6M

Sector Composition

Rank Sector Weight
1 Industrials 56.93%
2 Healthcare 26.58%
3 Consumer Staples 9.41%
4 Technology 7.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TRNS icon
1
Transcat
TRNS
$778M
$34.7M 37.91%
490,000
+40,000
+9% +$3.05M
ENOV icon
2
Enovis
ENOV
$1.69B
$16.1M 17.53%
300,000
+50,000
+20% +$2.58M
HEI.A icon
3
HEICO Corp Class A
HEI.A
$35.8B
$9.59M 10.47%
80,000
NOMD icon
4
Nomad Foods
NOMD
$1.73B
$8.62M 9.41%
500,000
+100,000
+25% +$1.58M
TECH icon
5
Bio-Techne
TECH
$11.2B
$8.29M 9.05%
+100,000
New +$7.94M
OTIS icon
6
Otis Worldwide
OTIS
$27.3B
$7.83M 8.55%
100,000
TYL icon
7
Tyler Technologies
TYL
$13.3B
$6.49M 7.08%
20,000
+5,000
+33% +$1.63M
VRT icon
8
Vertiv
VRT
$87.6B
-1,600,000
Closed -$15.6M

Similar funds

Broadcrest Asset Management's Q4 2022 Portfolio in Review

As of Q4 2022, Broadcrest Asset Management held 8 positions worth $91.6M, up 4.6% from $87.6M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Broadcrest Asset Management's Q4 2022 filing shows 1 new, 4 increased and 1 closed positions. Its largest new stake was Bio-Techne: 100,000 shares worth $8.29M. The largest sale was Vertiv, an estimated $15.6M.

By sector, the portfolio is most concentrated in Industrials at 57% of assets, down from 74% a quarter earlier, followed by Healthcare and Consumer Staples.

  • Broadcrest Asset Management's largest Q4 2022 buy was Bio-Techne: 100,000 shares worth $8.29M.
  • Broadcrest Asset Management added most to Transcat in Q4 2022, an estimated $3.05M increase.
  • Broadcrest Asset Management fully exited Vertiv in Q4 2022, selling an estimated $15.6M.
  • Broadcrest Asset Management's ten largest holdings make up 100% of its $91.6M portfolio in Q4 2022.
  • Broadcrest Asset Management opened 1 new position and closed 1 in Q4 2022.
  • Broadcrest Asset Management's portfolio value rose 4.6% quarter-over-quarter to $91.6M.

Based on Broadcrest Asset Management's 13F filing for Q4 2022, filed 7 Feb 2023.